DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (1729)
Death (95)
Life Threatening Events (62)
Disability (63)

Reports by Reaction Type

Anaemia (322)Nausea (195)Fatigue (185)Rash (166)Decreased Appetite (127)Vomiting (124)Weight Decreased (121)Asthenia (117)Haemoglobin Decreased (112)Malaise (104)Dyspnoea (99)White Blood Cell Count Decreased (93)

Below are a few examples of reports where side effects / adverse reactions may be related to PEG-Intron (Peginterferon Alfa-2B). For a complete list or a specific selection of reports, please use the links above.

Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Germany on 2012-08-27

Patient:

Reactions: Maternal Exposure Before Pregnancy, Abortion Induced

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis
    End date: 2012-01-01

Rebetol
    Dosage: unk
    End date: 2012-01-01

Victrelis
    Dosage: 200 mg, qd
    Indication: Hepatitis
    Start date: 2012-01-09
    End date: 2012-05-01

Other drugs received by patient: Lexotanil



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Injection Site Erythema, Nasal Dryness, Epistaxis

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-16

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-16

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-08-20



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Fatigue, Nausea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw

Rebetol
    Administration route: Oral

Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Psychiatric Symptom

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-13

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-16

Telavic
    Dosage: cumulative dose: 56250 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Other drugs received by patient: Loxoprofen; Allopurinol



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Back Pain, Drug Ineffective, Swelling

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-08-21



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Back Pain

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Rebetol
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Administration route: Oral
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Pancreatitis Acute, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-15

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Telaprevir
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Start date: 2012-06-19

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-19

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-03

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Start date: 2012-06-19



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Exposure VIA Father

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise, Renal Impairment, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-12

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-14

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-07-13

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-07

Other drugs received by patient: Lendormin; Lansoprazole; Amoban



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Gingival Pain, Glossodynia, Stomatitis, LIP Pain

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Interstitial Lung Disease, Oedema, Hepatic Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, once
    Administration route: Oral
    Indication: Adverse Event
    End date: 2012-06-09

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Other drugs received by patient: Urso 250; Lasix; Celestamine TAB; NEO-Minophagen C; Aldactone



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-16

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-17

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-08-12



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-07

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-30

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-06-24

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-08

Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-04

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-08

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-02-07

Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, qw
    Start date: 2012-05-02
    End date: 2012-05-02

PEG-Intron
    Dosage: 40 microgram, qw
    Start date: 2012-06-06
    End date: 2012-06-20

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-04-18
    End date: 2012-04-18

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-04-11

PEG-Intron
    Dosage: 30 microgram,
    Start date: 2012-06-27
    End date: 2012-06-27

PEG-Intron
    Dosage: 75 microgram, qw
    Start date: 2012-04-25
    End date: 2012-04-25

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-05-09
    End date: 2012-05-30

PEG-Intron
    Dosage: 40 microgram, unk
    Start date: 2012-07-04

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11

Telavic
    Dosage: 1.5 g, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-04-14

Telavic
    Dosage: 1.5 g, qd
    Administration route: Oral
    End date: 2012-06-27

Telavic
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-17

Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Liver Injury, Viral Load Increased, Drug Ineffective

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2009-01-01
    End date: 2010-01-01

Pegasys
    Dosage: unk
    Start date: 2012-06-28
    End date: 2012-08-02

Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-01-01
    End date: 2011-01-01

Rebetol
    Dosage: unk
    Start date: 2012-06-28
    End date: 2012-08-02

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-01-01
    End date: 2011-01-01

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-28
    End date: 2012-08-02



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-15
    End date: 2012-07-13

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Other drugs received by patient: Diflunisal; Januvia; Basen



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Renal Impairment, Anaemia, Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-24

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-25

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-17

Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible PEG-Intron side effects in 59 year old female

Reported by a physician from Canada on 2012-08-27

Patient: 59 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: Oesophageal Varices Haemorrhage, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: 120 unk, unk
    Indication: Hepatitis C

Other drugs received by patient: Nadolol; Lasix; Atenolol; Spironolactone; Eprex



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Irritability, Fatigue

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-05-16

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Orgasuline Rapide; Antiviral (Unspecified)



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, NO Adverse Event, Underdose

Drug(s) suspected as cause:
PEG-Intron

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014